John Lemkey
2019
In 2019, John Lemkey earned a total compensation of $1.5M as Chief Operating Officer at Odonate Therapeutics, a 79% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $114,600 |
|---|---|
| Option Awards | $1,085,470 |
| Salary | $272,925 |
| Other | $52,114 |
| Total | $1,525,109 |
Lemkey received $1.1M in option awards, accounting for 71% of the total pay in 2019.
Lemkey also received $114.6K in non-equity incentive plan, $272.9K in salary and $52.1K in other compensation.
Rankings
In 2019, John Lemkey's compensation ranked 7,238th out of 13,971 executives tracked by ExecPay. In other words, Lemkey earned more than 48.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,238 out of 13,971 | 48th |
Division Manufacturing | 2,787 out of 5,701 | 51st |
Major group Chemicals And Allied Products | 1,037 out of 2,200 | 53rd |
Industry group Drugs | 882 out of 1,886 | 53rd |
Industry Pharmaceutical Preparations | 653 out of 1,398 | 53rd |
Source: SEC filing on May 15, 2020.
Lemkey's colleagues
We found two more compensation records of executives who worked with John Lemkey at Odonate Therapeutics in 2019.